CLYM
Climb Bio, Inc.
NASDAQ · Healthcare · Biotechnology · US
$15.52
+6.37%0
Insider buys (3m)
1
Insider sells (3m)
-$407.0K
Net value (3m)
+47.6%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jul 1, 2026 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | A-Award | 70,284 | $13 |
| Jul 1, 2026 | Celebi Breanna Maurine · director | A-Award | 70,284 | $13 |
| Jun 30, 2026 | Brennan Aoife · director, officer: President and CEO | M-Exempt | 68,750 | $0.00 |
| Jun 30, 2026 | Brennan Aoife · director, officer: President and CEO | Sale | 30,902 | $13 |
| Jun 8, 2026 | WILLIAMS DOUGLAS E · director | A-Award | 40,000 | $11 |
| Jun 8, 2026 | Cumbo Alexander · director | A-Award | 40,000 | $11 |
| Jun 8, 2026 | Dunn Judith · director | A-Award | 40,000 | $11 |
| Jun 8, 2026 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | A-Award | 40,000 | $11 |
| Jun 8, 2026 | Levin Andrew David · director | A-Award | 40,000 | $11 |
| Jun 8, 2026 | Drapkin Kimberlee C · director | A-Award | 40,000 | $11 |
| Jun 8, 2026 | Thomas Stephen Basil · director | A-Award | 40,000 | $11 |
| Apr 29, 2026 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | A-Award | 2,106,000 | $0.00 |
| Feb 27, 2026 | Thomas Stephen Basil · director | Sale | 33,687 | $7.00 |
| Feb 27, 2026 | Thomas Stephen Basil · director | Sale | 16,313 | $7.01 |
| Feb 17, 2026 | Thomas Stephen Basil · director | Sale | 10,000 | $5.81 |
| Feb 17, 2026 | Thomas Stephen Basil · director | Sale | 90,000 | $5.23 |
| Jan 8, 2026 | Driscoll Cindy · officer: Senior Vice President, Finance | A-Award | 100,000 | $3.81 |
| Jan 8, 2026 | ALTSCHULLER Susan · officer: Chief Financial Officer | A-Award | 142,500 | $3.81 |
| Jan 8, 2026 | Wilson Perrin Megan · officer: Chief Business Officer | A-Award | 300,000 | $3.81 |
| Jan 8, 2026 | Brennan Aoife · director, officer: President and CEO | A-Award | 700,000 | $3.81 |
| Jan 7, 2026 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | Purchase | 7,111 | $3.50 |
| Dec 15, 2025 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | Purchase | 101,462 | $2.86 |
| Dec 15, 2025 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | Purchase | 213,099 | $2.18 |
| Dec 15, 2025 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | A-Award | 20,440,000 | $0.00 |
| Oct 1, 2025 | ALTSCHULLER Susan · officer: Chief Financial Officer | A-Award | 600,000 | $1.97 |
| Aug 11, 2025 | Thomas Stephen Basil · director | A-Award | 100,375 | $0.00 |
| Jul 1, 2025 | Brennan Aoife · director, officer: President and CEO | Sale | 20,618 | $1.22 |
| Jul 1, 2025 | Brennan Aoife · director, officer: President and CEO | M-Exempt | 68,750 | $0.00 |
| Jul 1, 2025 | Thomas Stephen Basil · director | M-Exempt | 25,094 | $0.00 |
| Jun 20, 2025 | Driscoll Cindy · officer: Senior Vice President, Finance | A-Award | 200,000 | $1.20 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 1, 2026